Intellipharmaceutics International Inc. , a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today reported the results of operations for the three and nine months ended August 31, 2013.
http://www.drugs.com/news/intellipharmaceutics-announces-third-quarter-2013-results-47869.html?
http://www.drugs.com/news/intellipharmaceutics-announces-third-quarter-2013-results-47869.html?
No comments:
Post a Comment